Prognostic Indicators in H7N9 Avian Influenza: A Systematic Review of Case Reports - Report - MDSpire

Prognostic Indicators in H7N9 Avian Influenza: A Systematic Review of Case Reports

  • By

  • Fengying Li

  • Kai Song

  • Xiaobin Ren

  • February 18, 2026

  • 0 min

Share

Clinical Report: Prognostic Indicators in H7N9 Avian Influenza

Overview

This systematic review evaluates prognostic indicators in H7N9 avian influenza, highlighting the impact of age, underlying health conditions, and antiviral treatment on patient outcomes. The findings underscore the importance of timely diagnosis and treatment in improving survival rates.

Background

The H7N9 avian influenza virus, first identified in 2013, poses a significant global health threat due to its high mortality rate and potential for severe respiratory illness. Understanding the factors influencing prognosis is critical for optimizing treatment strategies and improving patient outcomes. This review aims to consolidate existing knowledge on clinical features and mortality risks associated with H7N9 infection.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Advanced age is associated with a higher risk of death in H7N9 patients.
  • Underlying conditions such as hypertension, diabetes, and chronic respiratory diseases exacerbate illness severity.
  • Timely administration of antiviral medications, particularly oseltamivir, is crucial for improving survival rates.
  • Early diagnosis and treatment significantly impact patient outcomes.
  • Comprehensive research is needed to clarify the interactions among various prognostic factors.

Clinical Implications

Healthcare professionals should prioritize early diagnosis and prompt antiviral treatment for suspected H7N9 cases to enhance survival chances. Awareness of patient-specific factors, such as age and comorbidities, is essential for tailoring treatment strategies.

Conclusion

The systematic review highlights critical prognostic factors in H7N9 avian influenza, emphasizing the need for timely intervention to improve patient outcomes. Continued research is necessary to deepen understanding of these factors and their interactions.

Related Resources & Content

  1. Infection, The Ongoing Threat of Avian Influenza in Asia: Persistent Zoonotic Risks, 2025 -- https://link.springer.com/article/10.1007/s15010-025-02681-y
  2. Open Forum Infectious Diseases, Development of a Combined Clinical and Research-Developed Testing Strategy for Highly Pathogenic Avian Influenza A Virus H5, 2025 -- https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofaf744/8376911
  3. The Journal of Infectious Diseases, Avian Influenza Virus A(H5N1) Genotype D1.1 Is Better Adapted to Human Nasal and Airway Organoids Than Genotype B3.13, 2025 -- https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaf598/8341570
  4. Open Forum Infectious Diseases, Feline Infections with Avian Influenza Virus: A Comprehensive Review of Two Decades of Research, 2025 -- https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofaf261/8123920
  5. WHO, Influenza (avian and other zoonotic), 2025 -- https://www.who.int/westernpacific/newsroom/fact-sheets/detail/influenza-%28avian-and-other-zoonotic%29
  6. WHO, Clinical practice guidelines for influenza, 2024 -- https://www.who.int/publications/i/item/9789240097759
  7. Prognostic factors in H7N9 avian influenza: a systematic review based on case reports, 2024 -- https://pmc.ncbi.nlm.nih.gov/articles/PMC13020402/?utm_source=openai
  8. Influenza (avian and other zoonotic)
  9. Clinical practice guidelines for influenza
  10. Prognostic factors in H7N9 avian influenza: a systematic review based on case reports - PMC

Original Source(s)

Related Content